Navigation Links
Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic
Date:9/25/2007

with or without an antibiotic."

Anthim(TM) Background

Anthim is high affinity monoclonal antibody that targets the protective antigen component of anthrax infection, blocking the bacteria's ability to form deadly toxins. It is being developed for prophylaxis and post-exposure treatment of inhalation anthrax. Anthim has been granted Fast Track status and Orphan Drug Designation by the FDA and is being developed under the FDA Animal Rule, a regulatory process specifically designed for the development of medical countermeasures to bioterror threats. In April of 2007, Anthim was selected to R&D Directions' list of "100 Great Investigational Drugs.

About Elusys' Heteropolymer Antibody(TM) Technology

HP Antibodies represent a new approach for the treatment of antibiotic resistant infections distinct from traditional therapies. HP Antibodies utilize natural immune system mechanisms to clear pathogens and provide a means to develop novel drug candidates targeted against bacterial, viral and fungal infections. By targeting a unique immune receptor, HP Antibodies enhance a natural clearance mechanism and direct the rapid removal of pathogens from the circulation to tissue macrophages. Elusys is currently working on novel approaches to the treatment of Staphylococcus and Candida infections using HP antibodies.

About Elusys

Elusys is a privately held biopharmaceutical company focused on the development of antibody-based therapeutics for the treatment of life- threatening infectious disease. Current venture investors include Essex Woodlands Health Ventures LLC, Invesco Private Capital, Crescendo Ventures, MedImmune Ventures and Pfizer. For more information please visit http://www.elusys.com.


'/>"/>
SOURCE Elusys Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pelosi: Bush Veto of Stem Cell Bill Says No to the Hopes of Million of Families Across America
2. Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
5. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
6. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
7. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
8. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
9. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
10. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
11. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... BROOKFIELD, Wis. , March 27, 2015 /PRNewswire/ ... 40,000 unit shipments of incontinence devices for women. ... terrific, but the most gratifying part is the ... receive from women whose lives have been positively ... , president of InControl. InControl recently ...
(Date:3/27/2015)... 27, 2015  Johnson & Johnson (NYSE: JNJ ) ... (Eastern Time) on Thursday, April 23, 2015, from the State ... Investors and other interested parties may access the live ... at www.jnj.com and clicking on the webcast icon. ... be made available a few hours after the live meeting ...
(Date:3/27/2015)... YORK , March 27, 2015 /PRNewswire/ ... the leading source of health information, today ... the new National Action Plan for ... President Obama emphasized the urgency and importance ... on national and global health.    ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3
... Healthcare Network today announced that Outreach Services has agreed ... company will be named Cardon Outreach, and will be ... core business of both companies is providing revenue cycle ... their patient populations.  Cardon Outreach will serve over 500 ...
... Mich., Jan. 24, 2012 Validation & Compliance Institute (VCI) announces ... and Food companies are struggling with: How can ... breaking the bank? Experts have found that the ... for knowledge retention.  That way there are no excuses.  Big companies ...
Cached Medicine Technology:Outreach Services Merger With Cardon Healthcare Creates Largest Provider of Eligibility Services to Hospitals 2Validation & Compliance Institute Provides Affordable Online FDA Training 2
(Date:3/29/2015)... New York, NY (PRWEB) March 29, 2015 ... testosterone treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) pending in ... has scheduled the litigation’s next Case Management Conference ... indicate that the meeting will address the progress ... men who allegedly experienced heart attacks, strokes and ...
(Date:3/29/2015)... March 29, 2015 “Health is an ... as we learn more about the cannabinoid system … ... March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ new ... endo-healing, is celebrated. Publius, of The Cannabis Papers: A ... Institutes of Health (PubMed) cannabinoid system (CS) articles discussing: ...
(Date:3/28/2015)... Take a bite of warm, gooey pepperoni pizza, and ... the stomach, ready to break down your meal. In ... run amok, triggering a burning sensation in the chest. ... million Americans have heartburn at least once a month. ... it can be stopped. , Heartburn or acid reflux ...
(Date:3/28/2015)... 2015 India Network visitor health ... available to all visitors who purchase the plan before ... are encouraged to purchase the insurance program as soon ... proper coverage for pre-existing medical conditions. Parents and grandparents ... medical conditions with serious consequences to their health. Many ...
(Date:3/28/2015)... 28, 2015 How best to treat ... field in orthopaedic medicine. While diagnostic hip injections are ... the pain etiology, research presented today at the American ... Day suggests that pain relief from this diagnostic injection ... , “Our study looked to assess if the ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 3Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2
... Regular use of laptop could damage your health and ... other serious orthopedic pain because of poor posture , ... traveling businessmen, students, executives and those who need convenience, ... and laptops soared in India last year. According to ...
... scale clinical trials in order to substantiate preliminary results. ... were a small scale study which not only looked at ... at its potential as a non-surgical penis enlargement product. ... development firm, the penis extender was shown to correct Peyronies ...
... ban on smoking in public places amid protests from bar ... severe and poorly executed. ,'The authorities didn't give ... and restaurants so most people have to resort to smoking ... Reykjavik bar and restaurant, told AFP. ,Due to ...
... of how some abnormal cells can avoid a biochemical program ... the damage, is giving investigators at St. Jude Children's Research ... survive and thrive. ,The St. Jude study also ... to block this backup program would allow that program to ...
... seized in the European Union in 2006, according to EU ... of all fake medicines seized in the EU last year ... three countries are responsible for more than 70 percent of ... fake medicines included Viagra, Cialis and Levitra but also other ...
... into Kerala, tourist resorts and ayurvedic spas are all ready ... is the best time for Ayurvedic treatment. ,Although ... recent years that it has become a huge selling point ... ,According to ayurveda specialists, the monsoon season is the ...
Cached Medicine News:Health News:Regular Use of Laptop Could Seriously Damage Your Health 2Health News:Urologists Begin Clinical Trials on Treatment of Peyronies Disease 2Health News:India Main Source of Counterfeit Medicines Seized in Europe 2Health News:India Main Source of Counterfeit Medicines Seized in Europe 3Health News:Ayurveda Resorts in Kerala Gear Up for the Monsoon Season 2Health News:Ayurveda Resorts in Kerala Gear Up for the Monsoon Season 3
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
This fixed-volume digital micropipet is used to accurately measure and transfer 50 microliters of solution....
50L...
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
Medicine Products: